1518560565806911488

Only 16-19% of Black cancer patients access an appropriate donor match for transplant. At #Tandem22, we shared data showing broad access to omidubicel helped to reduce racial disparities, improving health equity in allo-HSCT care. More here: https://t.co/fEUfvVbnQn https://t.co/zgh2X8LNbh

Send us a message